Sarepta Therapeutics, Inc.
SRPT
$103.03
-$2.53-2.40%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -19.18% | -30.87% | -21.51% | -26.11% | -15.74% |
| Total Receivables | 48.69% | 45.65% | 46.83% | 45.58% | 67.04% |
| Inventory | 132.29% | 131.93% | 114.12% | 84.30% | 58.29% |
| Prepaid Expenses | 10.94% | 11.69% | 24.96% | 19.44% | -6.75% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 149.40% | 311.40% | 243.63% | 184.45% | 57.77% |
| Total Current Assets | 19.16% | 9.57% | 8.53% | -0.94% | 0.84% |
|
|
|||||
| Total Current Assets | 19.16% | 9.57% | 8.53% | -0.94% | 0.84% |
| Net Property, Plant & Equipment | 36.84% | 29.17% | 23.67% | 53.37% | 45.76% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -9.23% | 41.38% | 56.80% | 301.86% | 290.87% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -18.73% | -11.26% | 8.52% | 8.78% | 1.88% |
| Total Assets | 21.40% | 15.76% | 9.55% | 5.38% | 4.35% |
|
|
|||||
| Total Accounts Payable | 30.03% | 35.05% | -2.17% | -14.22% | 72.01% |
| Total Accrued Expenses | 22.10% | 6.90% | -6.01% | -38.33% | -41.04% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -87.42% | 506.56% | 539.32% | 601.09% | 581.02% |
| Total Finance Division Other Current Liabilities | 41.53% | 79.45% | 74.73% | 49.93% | 7.40% |
| Total Other Current Liabilities | 41.53% | 79.45% | 74.73% | 49.93% | 7.40% |
| Total Current Liabilities | 11.94% | 55.19% | 38.07% | 13.38% | 5.50% |
|
|
|||||
| Total Current Liabilities | 11.94% | 55.19% | 38.07% | 13.38% | 5.50% |
| Long-Term Debt | 0.41% | -8.15% | -8.15% | -8.15% | -26.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 36.54% | 26.16% | 11.17% | 159.78% | 144.82% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -21.74% | -28.62% | -27.03% | -27.06% | -8.40% |
| Total Liabilities | 1.26% | 1.43% | -1.56% | -3.57% | -12.33% |
|
|
|||||
| Common Stock & APIC | 8.19% | 6.32% | 5.55% | 4.51% | 23.45% |
| Retained Earnings | 5.29% | 2.71% | 1.06% | 0.38% | -13.71% |
| Treasury Stock & Other | -123.75% | 451.88% | 2.37% | -64.92% | 155.17% |
| Total Common Equity | 77.78% | 59.75% | 45.27% | 34.86% | 123.23% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 77.78% | 59.75% | 45.27% | 34.86% | 123.23% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 77.78% | 59.75% | 45.27% | 34.86% | 123.23% |
|
|
|||||
